MuSK-CAART
- Generic Name
- MuSK-CAART
Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
- First Posted Date
- 2022-07-11
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Cabaletta Bio
- Target Recruit Count
- 24
- Registration Number
- NCT05451212
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸UC Irvine, Department of Neurology, Orange, California, United States
🇺🇸UC Davis, Department of Neurology, Sacramento, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath